Showing results (1-10 of 337) with videos related to
Sort By:
Pageof 34
Pediatric Blood & Cancer|December 11, 2024
The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?Charles T Quinn, Russell E WareHaematologica|January 9, 2025
The modern use of hydroxyurea for children with sickle cell anemiaCharles T Quinn, Russell E WareClinical Pharmacokinetics|February 24, 2024
A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food EffectsAlina Sadaf, Min Dong, Amanda Pfeiffer, et al.Blood Advances|July 14, 2026
Seroprotection after Measles Vaccination in Children with Sickle Cell Anemia Receiving HydroxyureaAlexandra Power-Hays, Abigail Leigh Kincaid, Kathryn E McElhinney, et al.Hematology. American Society of Hematology. Education Program|December 6, 2015
Optimizing hydroxyurea therapy for sickle cell anemiaRussell E WareBlood|March 13, 2010
How I use hydroxyurea to treat young patients with sickle cell anemiaRussell E WareBritish Journal of Haematology|July 8, 2024
A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapyAlina Sadaf, Min Dong, Amanda Pfeiffer, et al.Pediatric Blood & Cancer|March 20, 2021
Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experienceKristine Karkoska, Kevin Todd, Omar Niss, et al.Blood Cells, Molecules & Diseases|August 30, 2017
Hydroxyurea: Analytical techniques and quantitative analysisAnu Marahatta, Russell E WarePageof 34